[CRISPR-Cas9-mediated CDC20 gene knockout inhibits cervical cancer cell proliferation, invasion and metastasis]

Yanxiu Mo1, Yang Shu2, Yulan Mo3

  • 1School of Basic Medical Sciences, Xiangnan University.

Abstract

Insights

Knocking down CDC20 in cervical cancer cells significantly reduces tumor growth, proliferation, and metastasis. This is linked to the Wnt/β-Catenin pathway, offering a potential therapeutic target for cervical cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Context:

  • Cervical cancer is a significant global health concern.
  • CDC20 is implicated in various cancers, but its role in cervical cancer requires further elucidation.
  • The Wnt/β-Catenin pathway is frequently dysregulated in cancer.

Purpose:

  • To investigate the impact of CDC20 knockdown on cervical cancer cell proliferation, migration, and invasion.
  • To explore the underlying molecular mechanisms, particularly the involvement of the Wnt/β-Catenin pathway.
  • To assess the therapeutic potential of targeting CDC20 in cervical cancer models.

Summary:

  • CDC20 and β-Catenin are upregulated in cervical cancer tissues.
  • CDC20 knockdown in C33A cervical cancer cells reduced proliferation, migration, and invasion, while increasing apoptosis.
  • CDC20 knockdown suppressed tumor growth in a xenograft mouse model and was associated with decreased β-Catenin levels, confirming interaction.
  • The study utilized CRISPR/Cas9 for gene editing, qRT-PCR, Western blotting, FACS, Transwell assays, and CoIP for comprehensive analysis.

Impact:

  • Provides evidence for CDC20 as a potential therapeutic target in cervical cancer.
  • Highlights the critical role of CDC20 in cervical cancer progression via the Wnt/β-Catenin pathway.
  • Offers a foundation for developing novel anti-cancer strategies targeting CDC20.

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
343
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K